Previous 10 | Next 10 |
Shares of Guardant Health (NASDAQ: GH) increased nearly 12% last month, according to data provided by S&P Global Market Intelligence . The liquid biopsy pioneer reported solid third-quarter 2019 operating results highlighted by revenue growth that continues to impress. In fact, the busi...
Introduction Over the past year, there has been a lot of coverage on Seeking Alpha about Exact Sciences ( EXAS ) and Guardant Health ( GH ), two companies playing in the emerging precision oncology space . This article focuses on comparing the two companies which are both chasing the same m...
Chances are, you know someone whose life has been affected by cancer, a disease that will kill more than 600,000 people in the United States this year. Guardant Health (NASDAQ: GH) is fighting back. The medical diagnostics company markets liquid biopsies (blood tests) that he...
Many things we spend on our money on are wants rather than needs. We could live without cars, smartphones, and streaming services if we had to. But what about healthcare? It's a need. What's more, demand for healthcare-related products and services is growing. An increasing senior population in...
In this week's episode of Industry Focus: Healthcare , host Shannon Jones talks with Motley Fool medtech guru Brian Feroldi about three earnings reports from three fantastic medtech companies: Guardant (NASDAQ: GH) , the leader in liquid biopsies, and the game-changing diabetes player...
Investment Thesis Guardant Health, Inc. ( GH ), a company providing cancer screening tests, has seen its top-line rising exponentially in recent quarters amid growing margins. The share price has surged ~17% higher since the recent upward guidance to 2019 outlook. The growing volumes and p...
Image source: The Motley Fool. Guardant Health Inc (NASDAQ: GH) Q3 2019 Earnings Call Nov 7, 2019 , 4:30 p.m. ET Operator Continue reading
Now is a great time to have biotech stocks in your portfolio. While biotech investing can be scary, because the small-cap companies are often unprofitable research-and-development labs, this is also where a lot of the cutting-edge science is happening. Let's see how Mirati Therapeutics (NA...
Guardant Health Inc (GH) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Carrie Mendivil – Investor Relations Helmy Eltoukhy – Co-Founder and Chief Executive Officers AmirAli Talasaz – President and Co-Founder Derek Bertocc...
Shares of Guardant Health (NASDAQ: GH) jumped 12% on Friday following the company's announcement of its third-quarter results after the market closed on Thursday. Guardant Health reported that its revenue skyrocketed 181% year over year in Q3 to $60.8 million. The company posted a net loss o...
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / ...
New research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New data show strong performance of Guardant Reveal™ in detection and quantification of residual disease in early-stage breast can...